ArticleSTAR protocols2022

Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson's disease.

Rubén Pavia-Collado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.